Multifaceted approaches to curtail aggressive end-of-life care must focus on the primary drivers of its prevalence, specifically hospital admissions in the patient's last 30 days and in-hospital mortality.Durable and frequent responses to programmed cell death 1 blockade are commonly observed in ...